Marta Lewandowska

Marta Lewandowska is a Program Lead at Mestag Therapeutics, bringing over 14 years of experience in the biopharmaceutical industry, working at antibody-based biotechs, including F-star developing antibody bispecifics, Crescendo focusing on antibody fragment technologies and Biosceptare utilising monoclonal antibodies in the field of immune-oncology. Marta has worked across the drug discovery process, from lead isolation to preclinical evaluation, with extensive experience in antibody engineering, protein sciences, display technologies and in vitro immune assays. Prior to Mestag, Marta held a position as a Team Leader at Iontas, where she was both a team and project leader responsible for implementing and executing antibody discovery campaigns for a range of drug discovery programs across oncology, immune-oncology and autoimmunity therapeutic areas.